Nobel Prize Honors Groundbreaking Body's Defenses Research

This year's prestigious award in medical science was granted for transformative findings that illuminate how the immune system targets dangerous pathogens while sparing the body's own cells.

A trio of renowned researchers—Japan's Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The work identified unique "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the organism.

The discoveries are now enabling innovative treatments for immune disorders and cancer.

The laureates will share a monetary award valued at 11m Swedish kronor.

Crucial Findings

"Their work has been decisive for understanding how the immune system functions and the reason we do not all develop serious self-attack conditions," commented the head of the award panel.

The team's studies address a fundamental mystery: In what way does the immune system protect us from countless invaders while leaving our healthy cells intact?

The body's protection system employs immune cells that scan for signs of disease, including pathogens and bacteria it has not met before.

Such defenders utilize detectors—called receptors—that are generated randomly in countless variations.

That provides the defense network the ability to fight a broad range of invaders, but the randomness of the process unavoidably creates white blood cells that may target the body.

Protectors of the Immune System

Scientists earlier understood that a portion of these harmful defense cells were eliminated in the thymus—the site where white blood cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "security guards"—which patrol the system to neutralize other defenders that attack the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee added, "The discoveries have laid the foundation for a new field of research and accelerated the creation of innovative treatments, for instance for tumors and autoimmune diseases."

In malignancies, regulatory T-cells block the body from attacking the tumor, so studies are focused on reducing their quantity.

For autoimmune diseases, experiments are exploring increasing regulatory T-cells so the body is not under attack. A comparable approach could also be effective in minimizing the risks of transplanted organ failure.

Pioneering Studies

Prof Sakaguchi, of Osaka University, conducted experiments on rodents that had their thymus removed, leading to autoimmune disease.

The researcher demonstrated that introducing defense cells from other mice could prevent the disease—implying there was a mechanism for blocking defenders from attacking the body.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in rodents and humans that resulted in the identification of a gene critical for the way regulatory T-cells function.

"The groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," commented a prominent physiology specialist.

"The work is a remarkable illustration of how fundamental physiological research can have broad implications for human health."